Late-onset sarcoidosis: A comparative study

Medicine

Volumn 91, Issue 3, 2012, Pages 137-143

  Varron, Loig ^a   Cottin, Vincent ^a   Schott, Anne Marie ^b,c   Broussolle, Christiane ^a   Sève, Pascal ^a  

^a CROIX ROUSSE HOSPITAL   (France)

^b Hôpital Cardiovasculaire et Pneumologique   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; HYDROXYCHLOROQUINE; METHOTREXATE; PREDNISONE;

ADULT; AGED; ARTICLE; ASPERGILLOMA; ASTHENIA; CATARACT; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DISEASE SEVERITY; ERYTHEMA NODOSUM; FEMALE; FEMUR HEAD NECROSIS; FOLLOW UP; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; ISCHEMIC HEART DISEASE; LUNG DISEASE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYOPATHY; MYOSITIS; ONSET AGE; OSTEOPOROSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SALIVARY GLAND; SARCOIDOSIS; SIDE EFFECT; SKIN BIOPSY; SKIN DEFECT; SURVIVAL RATE; TEACHING HOSPITAL; THORAX RADIOGRAPHY; TREATMENT OUTCOME; UVEITIS; WEIGHT GAIN;

AGE OF ONSET; AGED; AGED, 80 AND OVER; BIOPSY; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; SARCOIDOSIS; SARCOIDOSIS, PULMONARY; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 84861098090     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0b013e3182569f91     Document Type: Article

References (33)

1. Abad S, Meyssonier V, Allali J, Gouya H, Giraudet AL, Monnet D, Parc C, Tenenbaum F, Alberini JL, Grabar S, Pesce F, Rollot F, Sicard D, Dhote R, Blanche P, Brezin AP. Association of peripheral multifocal choroiditis with sarcoidosis: A study of thirtyyseven patients. Arthritis Rheum. 2004;51:974-982.
2. Baughman RP, Teirstein AS, Judson MA, Rossman MD, yeager H Jr, Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLennan G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL, Cherniak R. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164:1885-1889.
3. Berkmen yM. Radiologic aspects of intrathoracic sarcoidosis. Semin Roentgenol. 1985;20:356-375.
4. Blackburn D, Hux J, Mamdani M. Quantification of the risk of corticosteroidyinduced diabetes mellitus among the elderly. J Gen Intern Med. 2002;17:717-720.
5. Byg KE, Milman N, Hansen S. Sarcoidosis in Denmark 1980-1994. A registryybased incidence study comprising 5536 patients. Sarcoidosis Vasc Diffuse Lung Dis. 2003;20:46-52.
6. Chapelon C, Uzzan B, Piette JC, Jacques C, Coche E, Godeau P. ESarcoidosis in internal medicine. A cooperative study of 554 cases. Ann Med Interne (Paris). 1984;135:125-131.
7. Chapman JT, Mehta AC. Bronchoscopy in sarcoidosis: Diagnostic and therapeutic interventions. Curr Opin Pulm Med. 2003;9:402-407.
8. Chevalet P, Clement R, Rodat O, Moreau A, Brisseau JM, Clarke JP. Sarcoidosis diagnosed in elderly subjects: Retrospective study of 30 cases. Chest. 2004;126:1423-1430.
9. Clement DS, Postma G, Rothova A, Grutters JC, Prokop M, de Jong PA. Intraocular sarcoidosis: Association of clinical characteristics of uveitis with positive chest highyresolution computed tomography findings. Br J Ophthalmol. 2010;94:219-222.
10. DeRemee RA. The roentgenographic staging of sarcoidosis. Historic and contemporary perspectives. Chest. 1983;83:128-133.
11. Fretzayas A, Moustaki M, Vougiouka O. The puzzling clinical spectrum and course of juvenile sarcoidosis. World J Pediatr. 2011;7:103-110.
12. Herbort CP, Rao NA, Mochizuki M. International criteria for the diagnosis of ocular sarcoidosis: Results of the first International Workshop On Ocular Sarcoidosis (IWOS). Ocul Immunol Inf lamm. 2009;17:160-169.
13. Hernandez Blasco L, Sanchez Hernandez IM, Villena Garrido V, de Miguel Poch E, Nunez Delgado M, Alfaro Abreu J. Safety of the transbronchial biopsy in outpatients. Chest. 1991;99:562-565.
14. Hibberd C, yau JL, Seckl JR. Glucocorticoids and the ageing hippocampus. J Anat. 2000;197:553-562.
15. Hillerdal G, Nou E, Osterman K, Schmekel B. Sarcoidosis: Epidemiology and prognosis. A 15 year European study. Am Rev Respir Dis. 1984;130:29-32.
16. Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, Eklund A, Kitaichi M, Lynch J, Rizzato G, Rose C, Selroos O, Semenzato G, Sharma OP. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and Other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16:149-173.
17. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357:2153-2165.
18. Judson MA, Thompson BW, Rabin DL, Steimel J, Knattereud GL, Lackland DT, Rose C, Rand CS, Baughman RP, Teirstein AS. The diagnostic pathway to sarcoidosis. Chest. 2003;123:406-412.
19. Kaiser PK, Lowder CY, Sullivan P, Sanislo SR, Kosmorsky GS, Meziane MA, Rice TW, Smith SD, Meisler DM. Chest computerized tomography in the evaluation of uveitis in elderly women. Am J Ophthalmol. 2002;133:499-505.
20. Lenner R, Schilero GJ, Padilla ML, Teirstein AS. Sarcoidosis presenting in patients older than 50 years. Sarcoidosis Vasc Diffuse Lung Dis. 2002;19:143-147.
21. Mayock RL, Bertrand P, Morrison CE, Scott JH. Manifestations of sarcoidosis. Analysis of 145 patients, with a review of nine series selected from the literature. Am J Med. 1963;35:67-89.
22. Morimoto T, Azuma A, Abe S, Usuki J, Kudoh S, Sugisaki K, Oritsu M, Nukiwa T. Epidemiology of sarcoidosis in Japan. Eur Respir J. 2008;31:372-379.
23. Neville E, Walker AN, James DG. Prognostic factors predicting the outcome of sarcoidosis: An analysis of 818 patients. Q J Med. 1983;52:525-533.
24. Reynolds Hy. Sarcoidosis: Impact of other illnesses on the presentation and management of multiyorgan disease. Lung. 2002;180:281-299.
25. Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: A 5-year study in a health maintenance organization. Am J Epidemiol. 1997;145:234-241.
26. Sharma OP. Sarcoidosis in the aged. Geriatrics. 1973;28:76-85.
27. Siltzbach LE, James DG, Neville E, Turiaf J, Battesti JP, Sharma OP, Hosoda y, Mikami R, Odaka M. Course and prognosis of sarcoidosis around the world. Am J Med. 1974;57:847-852.
28. Souverein PC, Berard A, Van Staa TP, Cooper C, Egberts AC, Leufkens HG, Walker BR. Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based caseycontrol study. Heart. 2004;90:859-865.
29. Stadnyk AN, Rubinstein I, Grossman RF, Baum GL, Hiss y, Solomon A, Rosenthal T. Clinical features of sarcoidosis in elderly patients. Sarcoidosis. 1988;5:121-123.
30. Tachibana T, Iwai K, Takemura T. Sarcoidosis in the aged: Review and management. Curr Opin Pulm Med. 2010;16:465-471.
31. Wasfi yS, Rose CS, Murphy JR, Silveira LJ, Grutters JC, Inoue y, Judson MA, Maier LA. A new tool to assess sarcoidosis severity. Chest. 2006;129:1234-1245.
32. Watters LC, King TE, Schwarz MI, Waldron JA, Stanford RE, Cherniack RM. A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1986;133:97-103.
33. yanardag H, Pamuk ON. Older sarcoidosis patients: Experience of a medical center in Turkey. South Med J. 2004;97:472-474.